Akari Therapeutics Plc Adr (AKTX)

Feb 03, 2025

Major ADC Developer Akari Opens Direct Channel to Investors Through Webull Platform - StockTitan

Feb 03, 2025

Dec 28, 2024

Akari Therapeutics, Plc (NASDAQ:AKTX) Sees Significant Growth in Short Interest - Defense World

Dec 28, 2024

Dec 18, 2024

Akari Therapeutics appoints new CEO and board member - Investing.com

Dec 18, 2024

Dec 18, 2024

Akari Therapeutics names Samir Patel as CEO and adds board member - Investing.com India

Dec 18, 2024

Dec 18, 2024

Akari Therapeutics Names Interim CEO Patel as Permanent Chief, Adds Jazz Pharma Veteran to Board - StockTitan

Dec 18, 2024

Dec 16, 2024

Akari Therapeutics appoints new CFO - Investing.com

Dec 16, 2024

Dec 16, 2024

Akari Therapeutics appoints new CFO By Investing.com - Investing.com South Africa

Dec 16, 2024

Dec 16, 2024

AKTXAkari Therapeutics plc ADR (0.01 USD) Latest Stock News & Market Updates - StockTitan

Dec 16, 2024

Dec 16, 2024

Akari Therapeutics Strengthens Leadership: Former CFO Returns After $50M Fundraising Success - StockTitan

Dec 16, 2024

Nov 19, 2024

Akari Therapeutics Regains Nasdaq Compliance, Secures Market Listing Status | AKTX Stock News - StockTitan

Nov 19, 2024

Nov 14, 2024

Akari Therapeutics Announces Successful Completion of Merger of Akari Therapeutics and Peak Bio - Benzinga

Nov 14, 2024

Nov 14, 2024

Akari Therapeutics Completes Peak Bio Merger, Secures $53.2M in Financing Commitments | AKTX Stock News - StockTitan

Nov 14, 2024

Nov 08, 2024

Akari Therapeutics shareholders approve Peak Bio merger - Investing.com

Nov 08, 2024

Nov 08, 2024

Akari Therapeutics shareholders approve Peak Bio merger By Investing.com - Investing.com UK

Nov 08, 2024

Nov 08, 2024

Akari Therapeutics Announces Shareholder Approval in Connection With Peak Bio, Inc. Merger - StockTitan

Nov 08, 2024

Nov 01, 2024

European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN

Nov 01, 2024

Oct 15, 2024

Akari Therapeutics Announces Effectiveness of Form S-4 and General Meeting Date of November 7, 2024 Related to Peak Bio Merger - StockTitan

Oct 15, 2024

Oct 05, 2024

Akari Therapeutics Plc faces Nasdaq delisting over equity shortfall - Investing.com India

Oct 05, 2024

Sep 18, 2024

Akari Therapeutics PlcADR (AKTX) Price Target Increased by 45.45% to 81.60 - MSN

Sep 18, 2024

Sep 18, 2024

Akari Therapeutics appoints Rob Bazemore to board - Investing.com

Sep 18, 2024

Sep 17, 2024

Rob Bazemore Appointed to the Board of Directors of Akari Therapeutics - StockTitan

Sep 17, 2024

Aug 19, 2024

Akari Therapeutics Receives Positive and Constructive Pre-IND Feedback from US FDA for PAS-nomacopan in Treatment of Geographic Atrophy - StockTitan

Aug 19, 2024

Jun 05, 2024

Akari Therapeutics Announces Interim CEO Employment Contract Demonstrating Alignment with Shareholders - StockTitan

Jun 05, 2024

Sep 29, 2023

Akari Therapeutics Reports First Half 2023 Financial Results and Highlights - StockTitan

Sep 29, 2023

Mar 30, 2023

Akari Therapeutics, Plc Announces $4 Million Registered Direct Offering - StockTitan

Mar 30, 2023

Nov 04, 2022

Peak Bio (PKBO) Stock Price, News & Analysis - MarketBeat

Nov 04, 2022

Jan 20, 2021

The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Yahoo Finance

Jan 20, 2021

Jul 20, 2019

U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.25% - Investing.com Australia

Jul 20, 2019

Apr 24, 2017

Dow Jones News: Dow Rallies 200 Points After Macron and Le Pen Win First Round of French Election - Money Morning

Apr 24, 2017

Aug 18, 2016

Angion Biomedica (ANGN) Stock Price, News & Analysis - MarketBeat

Aug 18, 2016

Jul 27, 2011

ADVFN | Live Stock, Options & Crypto Market Data, Trading Tools & Community - ADVFN

Jul 27, 2011